PREVENT - Prospective Rhythm Event Surveillance in the ER With NetGuard
PREVENT
1 other identifier
interventional
287
1 country
2
Brief Summary
The purpose of this study is to determine the incidence of clinically significant rhythm and rate changes in ED patients who are not placed on conventional telemetry, and to test the user-friendliness of a automated clinician alter device in hectic and noisy setting of a busy emergency room.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2008
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 10, 2008
CompletedFirst Posted
Study publicly available on registry
September 11, 2008
CompletedSeptember 11, 2008
September 1, 2008
1 month
September 10, 2008
September 10, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of clinically significant rhythm and rate changes in ED patients.
Patient ED stay
Secondary Outcomes (1)
Measure of user-friendliness of the device.
Patient ED stay
Study Arms (1)
1
NO INTERVENTIONED patients that are not monitored with conventional therapy.
Interventions
Monitoring System for in-hospital patients who are typically unmonitored. Identifies and alarms for cardiac rhythm changes.
Eligibility Criteria
You may qualify if:
- \> 18 yes
- Agree to participate in study
- Telemetry not indicated
- Telemetry not available
- Willingness to complete a questionnaire-
You may not qualify if:
- Refusal to participate
- Know sensitivity to adhesive
- Language/communication barriers
- Perceived high risk for lack of study compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Dr Charles Pollack
Philadelphia, Pennsylvania, 19107, United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Charles Pollack, MD
Pennslvania Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 10, 2008
First Posted
September 11, 2008
Study Start
June 1, 2008
Primary Completion
July 1, 2008
Study Completion
July 1, 2008
Last Updated
September 11, 2008
Record last verified: 2008-09